Iovance Biotherapeutics
IOVA
IOVA
241 hedge funds and large institutions have $1.45B invested in Iovance Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 82 increasing their positions, 85 reducing their positions, and 26 closing their positions.
Holders
241
Holders Change
+5
Holders Change %
+2.12%
% of All Funds
4.17%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
32
Increased
82
Reduced
85
Closed
26
Calls
$19.6M
Puts
$3.25M
Net Calls
+$16.4M
Net Calls Change
+$2.37M
Top Buyers
1 |
1
Goldman Sachs
New York
|
$28.7M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$137M |
3 |
3
Two Sigma Investments
New York
|
$13.5M |
4 |
4
Renaissance Technologies
New York
|
$7.75M |
5 |
FC
5
Finepoint Capital
Boston,
Massachusetts
|
$15.2M |